CyberOptics Corporation 

(Public, NASDAQ:CYBE)   Watch this stock   
Find more results for CYBE
Oct 21, 2009
Q3 2009 Conference Call
Oct 21, 2009
Q3 2009 Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -9.84% -14.68%
Operating margin -20.16% -23.02%
EBITD margin - -19.49%
Return on average assets -6.38% -9.14%
Return on average equity -7.30% -10.34%
Employees 179 -

Address

5900 Golden Hills Drive
Minneapolis, MN 55416
United States - Map
+1-763-5425000 (Phone)
+1-763-5425103 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

CyberOptics Corporation discussions

  View all discussions »

Description

CyberOptics Corporation (CyberOptics) is a global supplier of optical process control sensors and inspection systems that are used to control the manufacturing process and to ensure the quality of electronic circuit boards manufactured by the customers using surface mount technology (SMT). The Company also manufactures and sells sensors that assist with yield improvement, and the placement and transport of wafers during semiconductor fabrication. It operates in two segments. The Electronic Assembly segment designs, manufactures and sells optical process control sensors and inspection systems for the electronic assembly equipment market. The Semiconductor segment designs, manufactures and sells optical and other process control sensors, and related equipment for the semiconductor capital equipment market.

Officers and directors

Kathleen P. Iverson
President, Chief Executive Officer, Director
Age: 53
Bio & Compensation - Reuters
Jeffrey A. Bertelsen
Chief Financial Officer, Vice President - Finance
Age: 46
Bio & Compensation - Reuters
Alex B. Cimochowski
Director
Age: 69
Bio & Compensation - Reuters
Irene M. Qualters
Director
Age: 59
Bio & Compensation - Reuters
Michael M. Selzer Jr.
Director
Age: 56
Bio & Compensation - Reuters